In studying the non-Hodgkin's lymphomas identification of the nature of neoplastic cells is usually based on immunological techniques, cytochemistry, and electron microscopy, using classical markers; for example, surface membrane and/or intracytoplasmic immunoglobulins, rosette formation with sheep erythrocytes, staining with heterologous T cell antisera, presence of Fc gamma and complement (C3) receptors, acid phosphatase and/or alpha-naphthyl acetate esterase activity, etc. The recent development of monoclonal antibodies directed against defined antigens present on subsets of lymphoid and histiocytic cells has created new possibilities to differentiate between the various types of large-cell lymphomas. ' In the present study 15 cases of large-cell lymphomas, classified as centroblastic (5), B-immunoblastic lymphoma (5) or histiocytic sarcoma (5) with conventional immunological markers, cytochemistry and electron microscopy and one case of malignant histiocytosis were investigated with a panel of monoclonal antibodies directed against antigens present on subsets of lymphoid, histiocytic and/or myeloid cells to find out whether the mentioned subtypes of large-cell lymphomas form immunologically heterogeneous groups. Moreover, the Accepted lor publication 2 August 1982 monoclonal antibodies were investigated for their diagnostic value in the differentiation of large-cell lymphomas.
Material and Methods

TISSUE PROCESSING
Each tissue specimen was cut into four pieces. One was fixed in buffered formalin (routine histology), one was fixed in a sublimate-formaldehyde mixture (immunohistochemistry),2 one was fixed in a fixative according to Burkhardt (plastic embedding),3 and one piece was snap-frozen in liquid nitrogen. For electron microscopy, eight small blocks of tissue had been cut from one of the four pieces before fixation or freezing. These blocks were fixed according to McDowell and Trump.4 Immunohistochemistrv Immunohistochemical investigation was carried out on paraffin-embedded sections (4,um) . It included staining with rabbit antibodies by an indirect immunoperoxidase technique for kappa and lambda light chains, alpha, gamma and mu heavy chains, lysozyme (all obtained from Dakopatts, Denmark), alpha-l-antitrypsin and alpha-l-antichymotrypsin (Behringwerke, Amsterdam).
Analysis oflarge-cell lymphomas using monoclonal aniid heterologolus tlltibo(lies As a second step a goat-antirabbit IgG tagged with horseradish peroxidase, prepared in our laboratory, was used. The specificity of these antibodies and the controls of the staining procedure have been described in detail before.5 The elastase antiserum used was a rabbitantihuman antibody, prepared by Dr JA Kramps from granulocytes. It was tested on a variety of normal and neoplastic tissues and cell suspensions and proved virtually specific in staining myeloid elastase6 (Table 1) .
Immunofluorescence These studies were performed on cryostat sections (4,um) using an indirect immunofluorescence technique with the 
Cytochemistrv
Cytochemical investigation was done on cryostat sections (8,urm) and included stainiing for acid phosphatase and alpha-naphthyl acetate esterase,9 alkaline phosphatase'°a nd 5-nucleotidase and adenosine triphosphatase.'
Electron Microscopy Small tissue blocks were postfixed in 1 5% osmium tetroxide and dehydrated in a graded series of alcohol solutions. The specimens were then embedded in Epon 812. A semithin section was used to select a representative area, the specimen was trimmed, cut ultrathin and stained with uranyl acetate and lead citrate.
DIAGNOSIS OF THE DIFFERENT SUBTYPES OF LARGE-CELL LYMPHOMA
The diagnosis of each subtype of lymphoma was based on the morphological criteria defined by Gerard-Marchant et al12 and Lennert et al'3 for the tumours of lymphoid origin and on the criteria of van der Valk et at5 14 for true histiocytic lymphomas. The diagnosis was supported by the following marker criteria:
Centroblastic lymphomas must have monoclonal surface immunoglobulins (slg) and moderate to strong C3 receptors as demonstrated with the red-cell overlayer technique but no or weak intracytoplasmic immunoglobulins (clg). B-immunoblastic lymphomas had both slg and clg but no or very weak C3 receptors.
Histiocytic sarcoma had no slg or clg, but showed C3 and Fc gamma receptors, diffuse granular, cytoplasmic acid phosphatase as well as alpha-naphthyl acetate esterase activity. Lysozyme, alpha-l-antitrypsin and/or alpha-l-antichymotrypsin were also demonstrable in the cytoplasm.
The one case of malignant histiocytosis showed the same marker characteristics as the histiocytic sarcomas. Percentage estlimated semiquantitativels trotil the total nlumlilber ol tumourcells Monoclonal antibodeles described in Table   4 -c lass ot inimunotlobuliln specificity are given in Table 1 . The anti-C3b receptor serum was prepared by immunising rabbits with highly purified human erythrocyte C3b receptors (anti-CR I). It was purified as described by Fearon.33 The antiserum recognises glycoprotein with a molecular weight of 213 000. In this study the IgG fraction of the antiserum was used. As a second step for the monoclonal mouse-antibodies a rabbit-antimouse IgG tagged with horseradish peroxidase (Dakopatts, Denmark) was used. The heterologous rabbit antisera (kappa, lambda, alpha, gamma, mu, anti C3b receptor and common acute lymphoblastic leukaemia antigen (CALLA)) were followed by the goat-antirabbit IgG, prepared in our laboratory. All antisera were first tested on normal tissues -for example, lymph node, spleen, tonsil, thymus, and for NA 1/34 and OKT6, on skin. Controls were performed by replacing the monoclonal antibody with phosphatebuffered saline.
Results
The results are summarised in Tables 2 (a) and (b). The histiocytic sarcomas showed a typical staining pattern. The tumour cells stained positive with TA1, antihuman monocyte I (Fig. 1) The centroblastic lymphomas showed a positive staining with the anti-C3b receptor (Fig. 2) pattern that resembled that of the centroblastic lymphomas was found, differences were noted. The staining for HLA-DR was strong to very strong in all but one case (case 4), while anti-C3b receptor staining was much weaker than in centroblastic lymphomas, or was absent. BA1 staining was observed in four or five cases varying from a few positive tumour cells (case 3 only) to a high proportion of tumour cell positive in cases I and 5. In two cases BA2 staining was found (cases 3 and 4). The staining pattern is illustrated in Fig. 3 .
With VIM-D5 and anti-elastase in some cases granulocytes were identified and BA2 was found to stain vessels and fibrocytes.
Discussion
Even though the number of cases investigated was small, the results of this study confirm the usefulness of monoclonal and heterologous antibodies in distinguishing effectively histiocytic sarcoma from B-immunoblastic and centroblastic lymphoma. A gradual difference was noted between these two B-lymphoid tumours, albeit a slight one. The neoplastic cells ofthe histiocytic sarcomas stained with the antibodies known to be reactive with antigens on monocytes/macrophages: antihuman monocyte I, OKM I and Macl (rather weak) TA 1, HLA-DR and anti-C3b receptor. This and the absence of staining with VIM-D5 and anti-elastase makes a myeloid origin of these tumours very unlikely. Staining with NAI/34 was also observed. This antiserum proved reactive with thymo- The reactive cells present in the tumour were also studied. Most of the large-cell lymphomas showed little admixture with reactive cells. Cases I and 5 of histiocytic sarcomas, case 2 of centroblastic and case 5 of B-immunoblastic lymphomas showed more substantial admixture. Whatever the number of admixed cells the pattern did not differ much; approximately equal numbers of T and B lymphocytes were found, with a tendency of predominance of the T cells. The distribution of the different T cell subsets showed a shift in the ration of helper/inducer (Leu3a/OKT4+) and suppressor/ cytotoxic (Leu2a/OKT8+) cells. This ratio normally is 2-3:1,38 but here varied between 1:1 and 2:1. This appeared to be slightly more pronounced in histiocytic sarcoma and centroblastic lymphoma but as the number of T lymphocytes was generally low, these findings must be interpreted with caution. Although no double-labelling experiments were done, studies on adjacent sections did not suggest that large numbers of cells positive for both Leu2a and Leu3a were present. Similarly, cells staining for both HLA-DR and Leu 1, the phenotype of activated T cells, were not present in large numbers though it was difficult to compare these two antigens in most cases of B-immunoblastic lymphomas where HLA-DR staining of tumour cells was strong. In both B-lymphoid tumours a fairly large number of macrophages/histiocytes was observed (up to 20% in one case).
In conclusion the monoclonal antibodies TA 1, antihuman monocyte 1, OKM 1, Macd and NA 1/34 can be used to differentiate histiocytic sarcoma from the other large-cell lymphomas. The differentiation between Bimmunoblastic and centroblastic lymphoma remains difficult, because the diagnostic classes appear to be morphologically and immunologically heterogeneous. The presence of strong HLA-DR staining, with weak or absent anti-C3b receptor staining and the presence or absence of BAI antigen may be helpful. The results underline the assumption that the diagnosis of nonHodgkin's lymphomas should not be based on studies with monoclonal and/or heterologous antibodies alone, but requires other techniques as well, such as cytochemistry, electron microscopy and morphometry. 
